Skip to main content
Top
Published in: Internal and Emergency Medicine 4/2015

01-06-2015 | EM - ORIGINAL

A retrospective cohort study examining the association between body mass index and mortality in severe sepsis

Authors: Timothy Glen Gaulton, C. Marshall MacNabb, Mark Evin Mikkelsen, Anish Kumar Agarwal, S. Cham Sante, Chirag Vinay Shah, David Foster Gaieski

Published in: Internal and Emergency Medicine | Issue 4/2015

Login to get access

Abstract

Body mass index (BMI) is an easily calculated indicator of a patient’s body mass including muscle mass and body fat percentage and is used to classify patients as underweight or obese. This study is to determine if BMI extremes are associated with increased 28-day mortality and hospital length of stay (LOS) in emergency department (ED) patients presenting with severe sepsis. We performed a retrospective chart review at an urban, level I trauma center of adults admitted with severe sepsis between 1/2005 and 10/2007, and collected socio-demographic variables, comorbidities, initial and most severe vital signs, laboratory values, and infection sources. The primary outcome variables were mortality and LOS. We performed bivariable analysis, logistic regression and restricted cubic spline regression to determine the association between BMI, mortality, and LOS. Amongst 1,191 severe sepsis patients (median age, 57 years; male, 54.7 %; median BMI, 25.1 kg/m2), 28-day mortality was 19.9 % (95 % CI 17.8–22.4) and 60-day mortality was 24.4 % (95 % CI 21.5–26.5). Obese and morbidly obese patients were younger, less severely ill, and more likely to have soft tissue infections. There was no difference in adjusted mortality for underweight patients compared to the normal weight comparator (OR 0.74; CI 0.42–1.39; p = 0.38). The obese and morbidly obese experienced decreased mortality risk, vs. normal BMI; however, after adjustment for baseline characteristics, this was no longer significant (OR 0.66; CI 0.42–1.03; p = 0.06). There was no significant difference in LOS across BMI groups. Neither LOS nor adjusted 28-day mortality was significantly increased or decreased in underweight or obese patients with severe sepsis. Morbidly obese patients may have decreased 28-day mortality, partially due to differences in initial presentation and source of infection. Larger, prospective studies are needed to validate these findings related to BMI extremes in patients with severe sepsis.
Appendix
Available only for authorised users
Literature
1.
go back to reference Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR (2001) Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29:1303–1310PubMedCrossRef Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR (2001) Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29:1303–1310PubMedCrossRef
2.
go back to reference Gaieski DF, Edwards JM, Kallan M, Carr BG (2013) Benchmarking the incidence and mortality of severe sepsis in the United States. Crit Care Med 41:1167–1174PubMedCrossRef Gaieski DF, Edwards JM, Kallan M, Carr BG (2013) Benchmarking the incidence and mortality of severe sepsis in the United States. Crit Care Med 41:1167–1174PubMedCrossRef
3.
go back to reference Nguyen HB, Rivers EP, Abrahamian FM et al (2006) Severe sepsis and septic shock: review of the literature and emergency department management guidelines. Ann Emerg Med 48:28–54PubMed Nguyen HB, Rivers EP, Abrahamian FM et al (2006) Severe sepsis and septic shock: review of the literature and emergency department management guidelines. Ann Emerg Med 48:28–54PubMed
4.
go back to reference Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM (2006) Prevalence of overweight and obesity in the United States, 1999–2004. JAMA 295:1549–1555PubMedCrossRef Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM (2006) Prevalence of overweight and obesity in the United States, 1999–2004. JAMA 295:1549–1555PubMedCrossRef
5.
go back to reference Troiano RP, Frongillo EA Jr, Sobal J, Levitsky DA (1996) The relationship between body weight and mortality: a quantitative analysis of combined information from existing studies. Int J Obes Relat Metab Disord 20:63–75PubMed Troiano RP, Frongillo EA Jr, Sobal J, Levitsky DA (1996) The relationship between body weight and mortality: a quantitative analysis of combined information from existing studies. Int J Obes Relat Metab Disord 20:63–75PubMed
6.
go back to reference Garrouste-Orgeas M, Troche G, Azoulay E et al (2004) Body mass index. An additional prognostic factor in ICU patients. Intensive Care Med 30:437–443PubMedCrossRef Garrouste-Orgeas M, Troche G, Azoulay E et al (2004) Body mass index. An additional prognostic factor in ICU patients. Intensive Care Med 30:437–443PubMedCrossRef
7.
go back to reference Tremblay A, Bandi V (2003) Impact of body mass index on outcomes following critical care. Chest 123:1202–1207PubMedCrossRef Tremblay A, Bandi V (2003) Impact of body mass index on outcomes following critical care. Chest 123:1202–1207PubMedCrossRef
8.
go back to reference El-Solh A, Sikka P, Bozkanat E, Jaafar W, Davies J (2001) Morbid obesity in the medical ICU. Chest 120:1989–1997PubMedCrossRef El-Solh A, Sikka P, Bozkanat E, Jaafar W, Davies J (2001) Morbid obesity in the medical ICU. Chest 120:1989–1997PubMedCrossRef
9.
go back to reference Goulenok C, Monchi M, Chiche J-D, Mira JP, Dhainaut JFo, Cariou A (2004) Influence of overweight on ICU mortality. Chest 125:1441–1445PubMedCrossRef Goulenok C, Monchi M, Chiche J-D, Mira JP, Dhainaut JFo, Cariou A (2004) Influence of overweight on ICU mortality. Chest 125:1441–1445PubMedCrossRef
10.
go back to reference Akinnusi ME, Pineda LA, El Solh AA (2008) Effect of obesity on intensive care morbidity and mortality: a meta-analysis. Crit Care Med 36:151–158PubMedCrossRef Akinnusi ME, Pineda LA, El Solh AA (2008) Effect of obesity on intensive care morbidity and mortality: a meta-analysis. Crit Care Med 36:151–158PubMedCrossRef
11.
go back to reference Frat JP, Gissot V, Ragot S et al (2008) Impact of obesity in mechanically ventilated patients: a prospective study. Intensive Care Med 34:1991–1998PubMedCrossRef Frat JP, Gissot V, Ragot S et al (2008) Impact of obesity in mechanically ventilated patients: a prospective study. Intensive Care Med 34:1991–1998PubMedCrossRef
12.
go back to reference Ray DE, Matchett SC, Baker K, Wasser T, Young MJ (2005) The effect of body mass index on patient outcomes in a medical ICU. Chest 127:2125–2131PubMedCrossRef Ray DE, Matchett SC, Baker K, Wasser T, Young MJ (2005) The effect of body mass index on patient outcomes in a medical ICU. Chest 127:2125–2131PubMedCrossRef
13.
go back to reference Sakr Y, Madl C, Filipescu D et al (2008) Obesity is associated with increased morbidity but not mortality in critically ill patients. Intensive Care Med 34:1999–2009PubMedCrossRef Sakr Y, Madl C, Filipescu D et al (2008) Obesity is associated with increased morbidity but not mortality in critically ill patients. Intensive Care Med 34:1999–2009PubMedCrossRef
14.
go back to reference Prescott HC, Chang VW, O’Brien JR, JM, Langa KM, Iwashyna T (2014) Obesity and 1-year outcomes in older americans with severe sepsis. Crit Care Med (Epub ahead of print) Prescott HC, Chang VW, O’Brien JR, JM, Langa KM, Iwashyna T (2014) Obesity and 1-year outcomes in older americans with severe sepsis. Crit Care Med (Epub ahead of print)
15.
go back to reference Shor-Posner G, Campa A, Zhang G et al (2000) When obesity is desirable: a longitudinal study of the Miami HIV-1-infected drug abusers (MIDAS) cohort. J Acquir Immune Defic Syndr 23:81–88PubMedCrossRef Shor-Posner G, Campa A, Zhang G et al (2000) When obesity is desirable: a longitudinal study of the Miami HIV-1-infected drug abusers (MIDAS) cohort. J Acquir Immune Defic Syndr 23:81–88PubMedCrossRef
16.
go back to reference Fleischmann E, Teal N, Dudley J, May W, Bower JD, Salahudeen AK (1999) Influence of excess weight on mortality and hospital stay in 1346 hemodialysis patients. Kidney Int 55:1560–1567PubMedCrossRef Fleischmann E, Teal N, Dudley J, May W, Bower JD, Salahudeen AK (1999) Influence of excess weight on mortality and hospital stay in 1346 hemodialysis patients. Kidney Int 55:1560–1567PubMedCrossRef
17.
go back to reference Grady KL, White-Williams C, Naftel D et al (1999) Are preoperative obesity and cachexia risk factors for post heart transplant morbidity and mortality: a multi-institutional study of preoperative weight-height indices. Cardiac Transplant Research Database (CTRD) Group. J Heart Lung Transplant 18:750–763PubMedCrossRef Grady KL, White-Williams C, Naftel D et al (1999) Are preoperative obesity and cachexia risk factors for post heart transplant morbidity and mortality: a multi-institutional study of preoperative weight-height indices. Cardiac Transplant Research Database (CTRD) Group. J Heart Lung Transplant 18:750–763PubMedCrossRef
18.
go back to reference Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW Jr (1999) Body-mass index and mortality in a prospective cohort of US adults. N Engl J Med 341:1097–1105PubMedCrossRef Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW Jr (1999) Body-mass index and mortality in a prospective cohort of US adults. N Engl J Med 341:1097–1105PubMedCrossRef
19.
go back to reference Hoit BD, Gilpin EA, Maisel AA, Henning H, Carlisle J, Ross J Jr (1987) Influence of obesity on morbidity and mortality after acute myocardial infarction. Am Heart J 114:1334–1341PubMedCrossRef Hoit BD, Gilpin EA, Maisel AA, Henning H, Carlisle J, Ross J Jr (1987) Influence of obesity on morbidity and mortality after acute myocardial infarction. Am Heart J 114:1334–1341PubMedCrossRef
20.
go back to reference Choban PS, Weireter LJ Jr, Maynes C (1991) Obesity and increased mortality in blunt trauma. J Trauma 31:1253–1257PubMedCrossRef Choban PS, Weireter LJ Jr, Maynes C (1991) Obesity and increased mortality in blunt trauma. J Trauma 31:1253–1257PubMedCrossRef
21.
go back to reference Hedlund J, Hansson LO, Ortqvist A (1995) Short- and long-term prognosis for middle-aged and elderly patients hospitalized with community-acquired pneumonia: impact of nutritional and inflammatory factors. Scand J Infect Dis 27:32–37PubMedCrossRef Hedlund J, Hansson LO, Ortqvist A (1995) Short- and long-term prognosis for middle-aged and elderly patients hospitalized with community-acquired pneumonia: impact of nutritional and inflammatory factors. Scand J Infect Dis 27:32–37PubMedCrossRef
22.
go back to reference Morris AE, Stapleton RD, Rubenfeld GD, Hudson LD, Caldwell E, Steinberg KP (2007) The association between body mass index and clinical outcomes in acute lung injury*. Chest 131:342–348PubMedCrossRef Morris AE, Stapleton RD, Rubenfeld GD, Hudson LD, Caldwell E, Steinberg KP (2007) The association between body mass index and clinical outcomes in acute lung injury*. Chest 131:342–348PubMedCrossRef
23.
go back to reference Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G (2003) SCCM/ESICM/ACCP/ATS/SIS. 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Crit Care Med 31(4):1250–1256PubMedCrossRef Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G (2003) SCCM/ESICM/ACCP/ATS/SIS. 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Crit Care Med 31(4):1250–1256PubMedCrossRef
24.
go back to reference Mikkelsen M, Miltiades A, Gaieski D et al (2009) Serum lactate is associated with mortality in severe sepsis independent of organ failure and shock. Crit Care Med 37(5):1670–1677PubMedCrossRef Mikkelsen M, Miltiades A, Gaieski D et al (2009) Serum lactate is associated with mortality in severe sepsis independent of organ failure and shock. Crit Care Med 37(5):1670–1677PubMedCrossRef
25.
go back to reference Knaus WA, Draper EA, Wagner DP, Zimmerman JE (1985) APACHE II: a severity of disease classification system. Crit Care Med 13:818–829PubMedCrossRef Knaus WA, Draper EA, Wagner DP, Zimmerman JE (1985) APACHE II: a severity of disease classification system. Crit Care Med 13:818–829PubMedCrossRef
26.
go back to reference Clinical Guidelines on the Identification (1998) Evaluation, and treatment of overweight and obesity in adults-the evidence report. National Institutes of Health. Obes Res 6(Suppl 2):51S–209S Clinical Guidelines on the Identification (1998) Evaluation, and treatment of overweight and obesity in adults-the evidence report. National Institutes of Health. Obes Res 6(Suppl 2):51S–209S
27.
go back to reference Maldonado G, Greenland S (1993) Simulation study of confounder-selection strategies. Am J Epidemiol 138:923–936PubMed Maldonado G, Greenland S (1993) Simulation study of confounder-selection strategies. Am J Epidemiol 138:923–936PubMed
28.
go back to reference Desquilbet L, Mariotti F (2010) Dose-response analyses using restricted cubic spline functions in public health research. Statist Med 29:1037–1057 Desquilbet L, Mariotti F (2010) Dose-response analyses using restricted cubic spline functions in public health research. Statist Med 29:1037–1057
29.
go back to reference Sakr Y, Elia C, Mascia L, Barberis B et al (2012) Being overweight or obese is associated with decreased mortality in critically ill patients: a retrospective analysis of a large regional Italian multicenter cohort. J Crit Care 27:414–721 Sakr Y, Elia C, Mascia L, Barberis B et al (2012) Being overweight or obese is associated with decreased mortality in critically ill patients: a retrospective analysis of a large regional Italian multicenter cohort. J Crit Care 27:414–721
31.
go back to reference Shah R, Hinkle CC, Haris L et al (2012) Adipose genes down-regulated during experimental endotoxemia are also suppressed in obesity. J Clin Endocrinol Metab 97:E2152–E2159PubMedCentralPubMedCrossRef Shah R, Hinkle CC, Haris L et al (2012) Adipose genes down-regulated during experimental endotoxemia are also suppressed in obesity. J Clin Endocrinol Metab 97:E2152–E2159PubMedCentralPubMedCrossRef
32.
go back to reference Stapleton RD, Dixon AE, Parsons PE et al (2010) The association between body mass index and plasma cytokine levels in patients with acute lung injury. Chest 138:568–577PubMedCentralPubMedCrossRef Stapleton RD, Dixon AE, Parsons PE et al (2010) The association between body mass index and plasma cytokine levels in patients with acute lung injury. Chest 138:568–577PubMedCentralPubMedCrossRef
33.
go back to reference Padwal RS, Pajewski NM, Allison DB, Sharma AM (2011) Using the Edmonton obesity staging system to predict mortality in a population-representative cohort of people with overweight and obesity. CMAJ 183(14):E1059–E1066PubMedCentralPubMedCrossRef Padwal RS, Pajewski NM, Allison DB, Sharma AM (2011) Using the Edmonton obesity staging system to predict mortality in a population-representative cohort of people with overweight and obesity. CMAJ 183(14):E1059–E1066PubMedCentralPubMedCrossRef
34.
go back to reference Wang HE, Griffin R, Judd S et al (2013) Obesity and risk of sepsis: A population-based cohort study. Obesity (Silver Spring) (Epub ahead of print) Wang HE, Griffin R, Judd S et al (2013) Obesity and risk of sepsis: A population-based cohort study. Obesity (Silver Spring) (Epub ahead of print)
Metadata
Title
A retrospective cohort study examining the association between body mass index and mortality in severe sepsis
Authors
Timothy Glen Gaulton
C. Marshall MacNabb
Mark Evin Mikkelsen
Anish Kumar Agarwal
S. Cham Sante
Chirag Vinay Shah
David Foster Gaieski
Publication date
01-06-2015
Publisher
Springer Milan
Published in
Internal and Emergency Medicine / Issue 4/2015
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-015-1200-1

Other articles of this Issue 4/2015

Internal and Emergency Medicine 4/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine